However, the vast majority of these adverse reports come from people who are recklessly abusing the peptide
These medications work by mimicking the action of the GLP-1 hormone that your body naturally produces after you eat
In a Phase 1 clinical trial, AMG133 demonstrated significant dose-dependent weight loss effects, achieving up to a 14.5% reduction in body weight compared to a 1.5% reduction for the placebo group on day 85
Current FDA Approvals for Pediatric Use The regulatory landscape is evolving rapidly
A common clinical clue: when a truly zinc-deficient patient responds, changes may be noticed in mental clarity, stress control, sleep, appetite, skin healing, taste, smell or tolerance of everyday stress
Diabetologia (2007) 50:94956